INS and lung adenocarcinoma: Notably, intracellular presence of insulin is associated with adverse prognosis in human lung adenocarcinoma [17]; High circulating IGF-1 levels are associated with increased risk of lung cancer [16], and inhibition of insulin/IGF-1 signaling inhibits growth of lung cancer cells [20].